JP2025134864A5 - - Google Patents
Info
- Publication number
- JP2025134864A5 JP2025134864A5 JP2025103497A JP2025103497A JP2025134864A5 JP 2025134864 A5 JP2025134864 A5 JP 2025134864A5 JP 2025103497 A JP2025103497 A JP 2025103497A JP 2025103497 A JP2025103497 A JP 2025103497A JP 2025134864 A5 JP2025134864 A5 JP 2025134864A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- cmklr1
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19306322.9 | 2019-10-09 | ||
| EP19306323.7A EP3804754A1 (en) | 2019-10-09 | 2019-10-09 | Cmklr1 agonists having a resolvin e1-like capability and their therapeutic applications |
| EP19306322 | 2019-10-09 | ||
| EP19306323.7 | 2019-10-09 | ||
| JP2022521452A JP7701915B2 (ja) | 2019-10-09 | 2020-10-09 | 抗ケモカイン様受容体１ヒト化抗体及びその治療適用 |
| PCT/EP2020/078488 WO2021069709A1 (en) | 2019-10-09 | 2020-10-09 | Anti-chemokin like receptor 1 humanized antibodies and their therapeutic applications |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521452A Division JP7701915B2 (ja) | 2019-10-09 | 2020-10-09 | 抗ケモカイン様受容体１ヒト化抗体及びその治療適用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025134864A JP2025134864A (ja) | 2025-09-17 |
| JP2025134864A5 true JP2025134864A5 (https=) | 2026-03-26 |
Family
ID=72811872
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521452A Active JP7701915B2 (ja) | 2019-10-09 | 2020-10-09 | 抗ケモカイン様受容体１ヒト化抗体及びその治療適用 |
| JP2025103497A Pending JP2025134864A (ja) | 2019-10-09 | 2025-06-19 | 抗ケモカイン様受容体１ヒト化抗体及びその治療適用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521452A Active JP7701915B2 (ja) | 2019-10-09 | 2020-10-09 | 抗ケモカイン様受容体１ヒト化抗体及びその治療適用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12534533B2 (https=) |
| EP (1) | EP4041302A1 (https=) |
| JP (2) | JP7701915B2 (https=) |
| KR (1) | KR20220087466A (https=) |
| CN (1) | CN114786722B (https=) |
| AU (1) | AU2020365034A1 (https=) |
| CA (1) | CA3156835A1 (https=) |
| CO (1) | CO2022004545A2 (https=) |
| CR (1) | CR20220155A (https=) |
| IL (1) | IL292029A (https=) |
| MX (1) | MX2022004312A (https=) |
| PE (1) | PE20221413A1 (https=) |
| PH (1) | PH12022550844A1 (https=) |
| WO (1) | WO2021069709A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024028509A2 (en) | 2022-08-05 | 2024-02-08 | Ose Immunotherapeutics | Treatment of an inflammation-associated disease in a patient expressing high chemerin level |
| WO2024028508A2 (en) | 2022-08-05 | 2024-02-08 | Ose Immunotherapeutics | Anti-chemokin like receptor 1 antibody or antigen-binding fragment thereof for use in the treatment of conditions associated with netosis |
| AU2024254671A1 (en) | 2023-03-30 | 2025-10-02 | Ose Immunotherapeutics | Method of synthesis of targeted lipid nanoparticle and uses thereof |
| WO2025242836A1 (en) | 2024-05-22 | 2025-11-27 | Ose Immunotherapeutics | Molecules comprising masking linkers and uses thereof for the treatment of auto-immune or inflammatory diseases and disorders |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| EP0690452A3 (en) | 1994-06-28 | 1999-01-07 | Advanced Micro Devices, Inc. | Electrically erasable memory and method of erasure |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| US20030096299A1 (en) * | 2001-07-09 | 2003-05-22 | Valerie Wittamer | Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
| US7419658B2 (en) * | 2001-07-09 | 2008-09-02 | Euroscreen S.A. | Isolated ligand of ChemerinR |
| US20050202029A1 (en) * | 2003-10-03 | 2005-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Family of cystatin-related chemoattractant proteins |
| US20070286863A1 (en) * | 2006-05-17 | 2007-12-13 | Christopher Sinal | CMKLR regulation of adipogenesis and adipocyte metabolic function |
| ATE542830T1 (de) | 2006-12-04 | 2012-02-15 | Pasteur Institut | Als gerüst verwendeter ob-fold zur entwicklung neuer spezifischer bindemittel |
| US8038992B2 (en) * | 2008-05-10 | 2011-10-18 | The Board Of Trustees Of The Leland Stanford Junior University | Target for regulating multiple sclerosis |
| JP2010229093A (ja) * | 2009-03-27 | 2010-10-14 | Banyu Pharmaceut Co Ltd | 新規ＣｈｅｍｅｒｉｎＲアゴニスト |
| US9726666B2 (en) * | 2011-06-13 | 2017-08-08 | Tla Targeted Immunotherapies Ab | Diagnosing and treating inflammatory diseases |
| WO2012172336A2 (en) * | 2011-06-13 | 2012-12-20 | Ith Immune Therapy Holdings | Treating inflammatory skin diseases |
| WO2013109543A1 (en) | 2012-01-20 | 2013-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Small molecule cmklr1 antagonists in demyelinating disease |
| JP5883515B2 (ja) | 2012-02-06 | 2016-03-15 | エーエスエムエル ネザーランズ ビー．ブイ． | 対象物を保持するための支持構造を備えるリソグラフィ装置及びそれに用いられる支持構造 |
| WO2018213592A1 (en) | 2017-05-19 | 2018-11-22 | J. Craig Venter Institute | Compositions and methods for resolution of inflammation |
| CN109942676B (zh) * | 2017-12-20 | 2021-06-11 | 深圳先进技术研究院 | 一种cmklr1拮抗多肽及其衍生物与应用 |
| JP2021520210A (ja) * | 2018-04-03 | 2021-08-19 | オーエスイー・イミュノセラピューティクス | 抗ケモカイン様受容体１抗体及びその治療応用 |
| EP3804754A1 (en) | 2019-10-09 | 2021-04-14 | OSE Immunotherapeutics | Cmklr1 agonists having a resolvin e1-like capability and their therapeutic applications |
-
2020
- 2020-10-09 WO PCT/EP2020/078488 patent/WO2021069709A1/en not_active Ceased
- 2020-10-09 US US17/767,606 patent/US12534533B2/en active Active
- 2020-10-09 CN CN202080084501.6A patent/CN114786722B/zh active Active
- 2020-10-09 AU AU2020365034A patent/AU2020365034A1/en active Pending
- 2020-10-09 KR KR1020227015533A patent/KR20220087466A/ko active Pending
- 2020-10-09 CA CA3156835A patent/CA3156835A1/en active Pending
- 2020-10-09 PH PH1/2022/550844A patent/PH12022550844A1/en unknown
- 2020-10-09 IL IL292029A patent/IL292029A/en unknown
- 2020-10-09 CR CR20220155A patent/CR20220155A/es unknown
- 2020-10-09 EP EP20789120.1A patent/EP4041302A1/en active Pending
- 2020-10-09 PE PE2022000588A patent/PE20221413A1/es unknown
- 2020-10-09 MX MX2022004312A patent/MX2022004312A/es unknown
- 2020-10-09 JP JP2022521452A patent/JP7701915B2/ja active Active
-
2022
- 2022-04-08 CO CONC2022/0004545A patent/CO2022004545A2/es unknown
-
2025
- 2025-06-19 JP JP2025103497A patent/JP2025134864A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025134864A5 (https=) | ||
| US20220267440A1 (en) | Anti-cd47 antibodies | |
| TWI830151B (zh) | 抗GPRC5DxBCMAxCD3三特異性抗體及其用途 | |
| TW202126694A (zh) | 標靶cd3的抗體、雙特異性抗體及其用途 | |
| US10308720B2 (en) | Multivalent and multispecific DR5-binding fusion proteins | |
| JP7257971B2 (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| TW201833141A (zh) | 抗b7-h3抗體、其抗原結合片段及其醫藥用途 | |
| RU2007139953A (ru) | Антитела к ccr5 и их применение | |
| JP2023120374A (ja) | ＲＧＭａ結合タンパク質及びその使用 | |
| JP7610515B2 (ja) | ヒト化抗Ｎ短縮型アミロイドβモノクローナル抗体 | |
| KR20120056800A (ko) | 글루글루카곤 수용체에 대한 항체와 이의 사용 | |
| CN104203977A (zh) | 结合肽聚糖识别蛋白1的抗体 | |
| US20240034783A1 (en) | Tumor-specific claudin 18.2 antibodies | |
| JPWO2021002312A1 (ja) | 抗ＥｐｈＡ４抗体 | |
| TW202448962A (zh) | 抗體、抗原結合片段和使用方法 | |
| TW202221041A (zh) | 一種結合人pd-l1的抗體 | |
| JP2025529812A (ja) | 甲状腺刺激ホルモン受容体に結合する抗体及びその使用 | |
| WO2024175030A1 (zh) | 抗Nectin-4抗体和包含其的多特异性抗体 | |
| JP7848181B2 (ja) | 抗原結合タンパク質 | |
| EP4396233A1 (en) | Polypeptides | |
| CN118459583B (zh) | 抗N3pGlu淀粉样蛋白β抗体及其用途 | |
| CA3143957A1 (en) | Anti-pd-l1 antibodies | |
| JP2019531732A (ja) | 抗ｃｄ２７抗体、その抗原結合性フラグメント、およびそのものの医学的使用 | |
| JP2022540904A (ja) | ヒトｔｒｅｍ－１に対する抗体およびその使用 | |
| KR20250027598A (ko) | Klrb1 결합제 및 이의 사용 방법 |